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A systematic review of physicians’ survival predictions in
terminally ill cancer patients
Paul Glare, Kiran Virik, Mark Jones, Malcolm Hudson, Steffen Eychmuller, John Simes,
Nicholas Christakis
Abstract
Objective To systematically review the accuracy of
physicians’ clinical predictions of survival in
terminally ill cancer patients.
Data sources Cochrane Library, Medline
(1996-2000), Embase, Current Contents, and
Cancerlit databases as well as hand searching.
Study selection Studies were included if a physician’s
temporal clinical prediction of survival (CPS) and the
actual survival (AS) for terminally ill cancer patients
were available for statistical analysis. Study quality was
assessed by using a critical appraisal tool produced by
the local health authority.
Data synthesis Raw data were pooled and analysed
with regression and other multivariate techniques.
Results 17 published studies were identified; 12 met
the inclusion criteria, and 8 were evaluable, providing
1563 individual prediction-survival dyads. CPS was
generally overoptimistic (median CPS 42 days,
median AS 29 days); it was correct to within one week
in 25% of cases and overestimated survival by at least
four weeks in 27%. The longer the CPS the greater
the variability in AS. Although agreement between
CPS and AS was poor (weighted  0.36), the two were
highly significantly associated after log transformation
(Spearman rank correlation 0.60, P < 0.001).
Consideration of performance status, symptoms, and
use of steroids improved the accuracy of the CPS,
although the additional value was small.
Heterogeneity of the studies’ results precluded a
comprehensive meta-analysis.
Conclusions Although clinicians consistently
overestimate survival, their predictions are highly
correlated with actual survival; the predictions have
discriminatory ability even if they are miscalibrated.
Clinicians caring for patients with terminal cancer
need to be aware of their tendency to overestimate
survival, as it may affect patients’ prospects for
achieving a good death. Accurate prognostication
models incorporating clinical prediction of survival
are needed.
Introduction
Diagnosis, treatment, and prognosis are the core clini-
cal skills fundamental to the good practice of medicine,
but the first half of the 20th century saw treatment dis-
place prognosis as the core skill accompanying
diagnosis.
1 The inception over the past 40 years of pal-
liative medicine as the study of the specialised care for
patients with incurable illnesses has led to a renewed
interest in prognostication.
“How long do I have, doctor?” is a central question
for patients with far advanced, incurable illnesses.
2
Accurate prognoses are important so that patients can
set appropriate goals and maximise their chances for
having the kind of death that most people say they
want. Accuracy of predicting survival is also a technical
prerequisite for good decision making by clinicians,for
study design and analysis by researchers,and for health
service planning by administrators concerned with
optimal end of life care. Because an accurate
communicated or formulated prediction of survival is
so relevant to the decisions that patients and doctors
make, knowing how well clinicians can predict survival
and whether modelling prognostic factors can add
value to clinicians’ predictions is important.
Several studies have suggested that contemporary
doctors are inaccurate and overly optimistic when pre-
dicting the survival of patients with terminal cancer.
3–5
The aim of this systematic review was to answer the fol-
lowing clinical questions related to clinical predictions
of survival. Do doctors overestimate or underestimate
the survival of terminally ill cancer patients on
average? How reliable are doctors in estimating
survival? Do doctors’ estimates of survival provide
information above and beyond prognostic or risk
factor models for outcome? We obtained individual
patient data from studies identified by a systematic
search strategy and did a meta-analysis to answer these
questions.
Methods
Systematic review
The systematic review followed the process described
in the Method for Evaluating Research and Guideline Evi-
dence (MERGE) document developed by the local
health authority.
6
Search strategy
We searched Ovid Premedline (Jan 2001) and Medline
(1966-2000), Embase, Current Contents, Cochrane
Library, and Cancerlit databases on 19 January 2001.
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neoplasms AND prognosis AND terminally ill, limited
to human studies,English language,and cohort studies
publication type. We also did a free text search using
the text words predict$, survival-analysis, incidence,
cohort-studies combined with prognos$, terminally ill,
and neoplas$. Next, we hand searched the references
sections of the electronically identified articles and a
book on prognostication at the end of life
7 in an
attempt to identify any articles missed by the electronic
search. Finally, we attempted to identify unpublished
studies, and a medical librarian advised on accessing
theses and trial registries.
We obtained potential papers and screened them
to see if they met the following preset selection criteria:
(a) the study involved patients with far advanced cancer
(that is, patients deemed “terminal” by the authors or
who were referred for hospice admission); (b) the
results section included a temporal survival prediction,
given in days or weeks, made prospectively for each
patient by a doctor; (c) the results section provided the
patients’ individual survival durations; and (d) the
methods section provided an explanation of how the
date of death was determined. If the raw data for clini-
cal prediction of survival (CPS) and actual survival (AS)
were not retrievable from the publication directly we
contacted the authors to obtain them. We excluded
papers if these data were neither retrievable from the
publication nor obtainable from the authors.
Appraising the quality of the articles
Three of us (PG, KV, and SE) then re-read studies
selected for inclusion in the review and independently
evaluated them for their quality by using the MERGE
guide for critical appraisal. As MERGE does not have a
specific checklist for studies of prognosis, we decided
that studies of accuracy of CPS resembled evaluation
of a diagnostic test in many ways,so we used the check-
list provided for that purpose. MERGE incorporates a
four point coding system for appraising the quality of a
study. These range from “a” (criterion entirely fulfilled)
through “b1” and “b2” to “c” (criterion not at all
fulfilled). The subcodes for each aspect of the study are
then summarised into a single code for the overall
assessment of quality, scoring the risk of bias from “A”
(low) through “B1” and “B2” to “C” (high).
Data abstraction
The individual patient data for CPS and AS could be
abstracted directly from papers if they were presented
as a table or scatter plot. When CPS and AS were pre-
sented in summarised form we sought the individual
patient data from the authors. We then entered all
available data into a spreadsheet for statistical analysis.
Quantitative data synthesis
We used descriptive statistics to summarise the data
(medians and ranges) by individual study and when
pooled. We determined the accuracy of predictions by
examining the absolute difference between CPS and
AS and the extent of agreement between CPS and AS,
measured by the weighted  statistic. Owing to the
skewed nature of survival data we decided to examine
the differences between CPS and AS after log transfor-
mation. We calculated Spearman’s rank correlation
between log(AS) and log(CPS). To simplify calcula-
tions, we rounded AS to the nearest month
(categorised together if more than six months). We
used one way analysis of variance to test for heterogen-
eity among the individual studies. We identified groups
of homogeneous studies by applying multiple com-
parisons with Tukey’s method.
As well as CPS and AS, data for 15 patient based
prognostic factors were also available from two of the
studies.We analysed these additional data together in a
combined data subset. We used multiple linear
regression to determine three predictive models for
log(AS): (a) study and log(CPS) alone; (b) the best
model allowing for study and prognostic factors only;
(c) the best model allowing for study, log(CPS), and
prognostic factors. We included the factor “study” in
the models because the patients differed significantly
in status (as measured by Karnofsky performance
status) between the two studies. We determined the
best model by backward elimination in each case,
retaining only statistically significant factors. To
evaluate the effect of the health status of patients on
accuracy of CPS, we regressed log(AS) against the vari-
ables identified in each of the three models according
to three subgroups of patients defined by Karnofsky
performance status ( < 40, 40-50, or ≥60).
Results
Study characteristics
Figure 1 shows the trial flow of the systematic review.
The electronic search produced 22 citations, yielding
six papers of apparent relevance.
4 8–12 The hand search
identified 11 other studies.
3 14–22 We identified one
unpublished study but were unable to contact the
author. No registered trials or theses were identified.
We obtained all 17 relevant,published papers.After
reading them, we excluded five that did not meet the
inclusion criteria (CPS not temporal or population not
limited to end stage cancer).
10 11 19 20 22 The remaining
12 studies document the CPS for 1983 patients. Data
on 1594 patients (80.3% of total) were available for
analysis from eight of the studies, and we entered these
into the meta-analysis.
3 4 8 13–16 21 Because some indi-
vidual CPS or AS data were missing, 1563 complete
CPS-AS dyads were available for analysis. We extracted
individual patient data from tables or figures of four
studies (n=296),
31 51 62 1 and the authors generously
provided us with their original data for the other four
(n=1280). The four studies that were excluded at this
stage either had no data available (n=3)
91 71 8 or
involved duplicate data (n=1).
12 Table 1 summarises
Potentially relevant studies identified and screened for inclusion (n=17)
Excluded (n=5)
(clinical prediction of survival not temporal
or not restricted to terminal cancer)
Retrieved for more detailed evaluation (n=12)
Included in the analysis (n=8)
Excluded because data not available (n=4)
Fig 1 Progress through the stages of the review
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review. Four were from the United Kingdom,
31 51 62 1
three were from Italy,
81 31 4 and one was from the
United States.
4 Two studies involved referring doc-
tors,
13 16 and the rest involved “receiving” doctors
(palliative care specialists). Three studies involved
patients in hospital,
31 62 1and the rest involved patients
being cared for at home. All studies involved patient
populations that were heterogeneous for the primary
cancer site.
Quantitative data synthesis
Validity assessment
All eight studies were assessed as being biased
(selection biases and misclassification biases), with half
being at a high risk. Selection biases included a narrow
spectrum of patients and failure to use an inception
cohort. Misclassification biases included the timing of
the prediction in relation to recruitment, variations in
clinical experience of the doctor making the predic-
tion, access to other clinical information when making
the prediction, and involvement of the predicting
doctor in providing ongoing care to the patient.
Simple summary results
When all 1563 evaluable CPS-AS dyads were pooled,
the median CPS was 42 days and the median AS was
29 days, a difference of 13 days. The overall range of
CPS was from zero days to more than two years, while
AS had a range from zero to almost 500 days. Table 1
summarises individual study values. Overall, CPS was
correct to within one week in 25% of cases, correct to
within two weeks in 43%, and correct to within four
weeks in 61%. CPS overestimated AS by at least four
weeks in 27% of cases and underestimated it by at least
four weeks in 12% of cases. Although the level of
agreement between CPS and AS was only fair
(weighted  0.36), the log transformation of CPS was
significantly correlated with the log transformation of
AS (Spearman rank correlation 0.60, t1540=32.3,
P < 0.001). The rank correlations between CPS and AS
for the individual studies ranged from 0.26 to 0.73,and
were ≥0.49 in all but one (study 3).
Figure 2 shows the range of AS, expressed in
months, for various categories of CPS. This box and
whisker plot shows the skewed distribution of AS,given
CPS and the increasing variability in AS as CPS
increases. When CPS exceeds six months it has no pre-
dictive value.Figure 2 also shows that for predictions of
up to six months the median survival increases in an
approximately linear fashion, even if it is inaccurate.
The positioning of the interquartile ranges confirms
physicians’ tendency to overestimate the survival of
terminally ill cancer patients;no more than one in four
outlived their prognosis when CPS was six months or
less.
Statistical aggregation
The patients in study 2 survived much longer than the
patients in the other seven studies, and studies 3 and 6
had the shortest survivals. With the exception of study
2, CPS consistently overestimated AS. Figure 3 shows
the median difference between AS and CPS, and its
associated 95% confidence interval, for each of the
eight studies; a lack of uniformity in the results is
apparent.
A statistical test for heterogeneity with a one way
analysis of variance confirmed significant heterogen-
eity between the studies (F7,1530=10.57, P < 0.001).
Tukey’s method of multiple comparisons suggested
four different groupings of homogeneous studies; the
discrepancy between CPS and AS was particularly
marked in study 3. Because of the strong indication of
heterogeneity, combining the data of the eight studies
for extensive statistical analysis was not appropriate,
which limited the aim of doing a comprehensive meta-
analysis.
Table 1 Summary of the eight studies included in the systematic review
Study
Quality
rating*
No of
sites/doctors
Individual
patient data
Median (IQR) CPS
(days)
Median (IQR) AS
(days)
Rank
correlation Weighted 
(1) Parkes, 1972
3 C 1/? 71 28 (24-56) 21 (9-34) 0.49 0.31
(2) Evans, 1985
15 C 1/6 42 81 (28-182) 120 (43-180) 0.69 0.40
(3) Heyse-Moore,1987
16 C 1/? 50 56 (33-84) 14 (7-28) 0.26 0.06
(4) Maltoni, 1994
13 B1 1/4 100 42 (28-56) 32 (13-63) 0.60 0.34
(5) Maltoni, 1995
8 B1 22/? 530 42 (28-70) 32 (13-62) 0.70 0.44
(6) Oxenham, 1998
21 C 1/5 21 21 (14-35) 15 (9-25) 0.73 0.52
(7) Maltoni, 1999
14 B1 14/? 451† 42 (21-70) 33 (14-62) 0.70 0.44
(8) Christakis, 2000
4 B1 5/343 326 77 (28-133) 24 (12-58) 0.50 0.25
Overall — — 1591 42 (28-84) 29 (13-62) 0.60 0.36
AS=actual survival; CPS=clinical prediction of survival; IQR=interquartile range; ?=number of clinicians making predictions either not published or not known.
*According to MERGE document: B1=low-moderate risk of bias; C=high risk of bias.
6
†Included 36 patients who were censored (that is, still alive).
Clinical prediction of survival
A c t u a l   s u r v i v a l   ( m o n t h s )
012312345
Week Month
6 7-9 10-1213-24 >24
0
10
15
5
5
Fig 2 Box and whisker plot of actual survival for various prediction
categories. The black boxes indicate the interquartile range of actual
survival, and the white bar is the median survival for that prognostic
category. The whiskers are drawn to 1.5 times the interquartile
range, which would represent the 99.65 centile if the data were
normally distributed, although they are not. Points beyond that range
are drawn individually
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In the subset of 981 patients with data for multiple
prognostic variables, log(CPS) was statistically signifi-
cantly correlated with log(AS) (t961= 31.93, P < 0.001).
The R square value of 0.51 indicates that greater than
50% of the variation in log(AS) was explained by
log(CPS). Next, we generated a model based on 15
patient based prognostic factors. Using backwards
elimination we found that anorexia (t974=7.50,
P < 0.001), dyspnoea (t974=3.00, P=0.003), blood trans-
fusion (t974=1.95, P=0.054), use of palliative steroids
(t974= 5.12, P < 0.001), and the log transformation of
the Karnofsky performance status (KPS) score
(t974= 16.62, P < 0.001) were all statistically significantly
correlated with log(AS). A combination of all these
prognostic factors accounted for only 35% of the vari-
ation in log(AS). Finally, when we added log(CPS) to
this model,blood transfusion was no longer statistically
significant. Thus palliative steroid use, anorexia,
dyspnoea, and log(KPS) all contributed additional
value to log(CPS) when predicting log(AS), but the
additional value was small (R square 0.54).
Prediction of AS according to health status
We repeated the models described above with the
patients divided into three subgroups based on
Karnofsky performance status scores: < 40 (n=330),
40-50 (n=457), and ≥60 (n=194). Table 2 shows R
square values obtained for each model, which indicate
that more accurate predictions are made for sicker
patients than for healthier ones. For each model,
log(CPS) explains more of the variation in log(AS) as
the patient becomes sicker. The additional value
provided by the other prognostic factors (anorexia,
dyspnoea, steroid use) changes little, irrespective of
how poor the patient’s performance is.
Discussion
Statement of principal findings
This systematic review of eight published studies that
cover more than 1500 predictions of survival by
doctors in three different countries over 30 years has
gone some of the way towards answering the three
questions of interest concerning clinical prediction of
survival (CPS). Doctors’ predictions for terminally ill
cancer patients (a population very close to death with a
median survival of approximately four weeks) were
inaccurate—they were correct to within a week in only
25% of cases and out by more than four weeks in a
similar number.Doctors consistently overestimated the
duration of survival in seven of the eight studies.
Despite being inaccurate, clinical predictions are clini-
cally useful; CPS and actual survival (AS) were strongly
correlated. Furthermore, our independent modelling
of supplementary data from two large Italian studies
included in the review indicated that CPS seems to be
better than conventional prognostic variables factors
used in this population, such as performance status
and symptoms, although CPS was more accurate in
patients with worse performance status. These factors
may help to refine the clinician’s prediction to a limited
extent. Our finding of the predominance of the CPS
over patient related measures such as performance
status and symptoms in predicting survival is also con-
sistent with that of investigators whose data were not
included in this review.
19 20 These results reaffirm the
importance of physicians’ judgment in an era of
expanding technology and dependence on test results.
The findings of this systematic review were also
able to clarify whether or not CPS is more accurate
closer to the event (referred to as the “horizon effect”
by meteorologists).
23 Because prognosis has a dynamic
quality, it may become more or less certain as time
passes. The horizon effect has only been studied to a
limited extent for CPS. One study (which did not meet
the inclusion criteria for this review) found evidence of
the horizon effect.
20 Another study (included in the
review) found that the extent of prognostic error varies
with both the CPS and the AS.
4 The results of the sys-
tematic review support the concept of the horizon
effect for CPS. Data were not available to answer some
of the other questions relating to CPS, such as whether
the demographics, training, or experience of the
doctor makes a difference, whether the nature of the
doctor-patient relationship does, or whether follow up
predictions are superior to initial ones.
Strengths and weaknesses: comparison with
previous studies
One previous qualitative systematic review on this
topic broadly addressed all known prognostic factors
in terminal cancer.
5 The authors also concluded that
CPS is one of the best predictors of survival and is cor-
related with AS. Our review extends those conclusions
by focusing on several questions relating to the charac-
teristics of the CPS and providing numerical answers
to better understand its clinical usefulness as well as its
limitations.
Attempting a quantitative analysis of this literature
presented several methodological challenges. Because
this is not a review of a healthcare intervention or con-
ventional diagnostic test, it falls outside the domain of
the Cochrane Collaboration. This was why we used the
Difference (days)
Clinician overpredicts Clinician underpredicts
Study 1
Study 2
Study 3
Study 4
Study 5
Study 6
Study 7
Study 8
-40 -20 0 20 40 60
Fig 3 Difference between actual survival and clinical prediction of
survival for terminally ill cancer patients (median and 95%
confidence interval)
Table 2 R square values obtained for three multiple linear regression models in 981
patients for whom data on multiple prognostic variables were available
Model KPS <40 KPS 40-50 KPS ≥60
CPS alone 0.46 0.35 0.24
Other prognostic factors alone 0.25 0.15 0.08
CPS and other prognostic factors 0.50 0.38 0.27
CPS=clinical prediction of survival; KPS=Karnofsky performance status score.
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undertaking a review. Identifying the studies to be
included was also problematic.
Our electronic search strategy lacked sensitivity;
only one in three relevant studies was located
electronically. One study was published in a journal
that was not indexed at the time of publication, and
others that were missed were indexed but were coded
under MeSH terms that we did not include in our
search strategy, such as forecasting, hospices, palliative
care, life expectancy, and time factors. Re-running the
electronic search with these new terms identified no
publication that was missed by our initial search meth-
ods but improved the sensitivity of the electronic
search. Although an established search strategy exists
for identifying studies of prognostic factors, the terms
needed to maximise the sensitivity of searches for stud-
ies of the accuracy of survival estimation in terminally
ill patients need further consideration. Furthermore,
some palliative care journals, especially non-English
language ones, are not registered on electronic
databases and their articles can only be located by
hand searching.
For appraising the quality of the studies two
over-riding issues arose. The first was deciding what
criteria to use, and the second was deciding how to
apply them. Although predicting survival has to do
with prognosis,studies to compare the accuracy of CPS
with AS are closer in concept to the evaluation of a
diagnostic test than to studies of prognosis. However,
unlike other test evaluations, no reference standard
exists with which CPS can be compared,other than the
outcome itself. This makes blinding and verification
bias irrelevant,but it reduces the usefulness of applying
quality criteria when appraising studies of CPS. As a
form of a diagnostic test, CPS predicts for a future
health state and so is similar to screening in its evalua-
tion.Therefore,the study population needs to be a well
defined inception cohort, and spectrum bias and loss
to follow up are important validity concerns.
Information about the experience, specialty, and train-
ing of the clinician making the predictions may also be
relevant and needs to be available. As associated
decisions about the application or withholding of life
sustaining treatments such as fluids or antibiotics will
also affect survival, the physician or investigator
making the prediction should not be responsible for
the patient’s clinical care. These are the types of prob-
lems with the quality of the studies in the review,and,in
the absence of established criteria, our quality ratings
may not be valid.
Although the heterogeneity of the studies pre-
vented us from doing a comprehensive meta-analysis,
some pooling of the data was still possible and we
believe our principal findings are valid. The multiple
comparisons indicated that the results of some of the
studies were sufficiently homogeneous to permit this
in a limited way, but such an approach was not consist-
ent with our original objective. Approximately three
quarters of the known data on the accuracy of CPS
were available to be analysed.If the data from the other
four studies had been available for inclusion, the prob-
lem of heterogeneity may have been lessened.
Possible explanations and implications
That doctors cannot predict the timing of death in ter-
minal cancer with much accuracy is not surprising, but
the fact that their predictions are highly correlated with
survival indicates that they are able to sense when
things are starting to go wrong. Epidemiologists and
other people who study the accuracy of predictions,
such as meteorologists, decompose prediction accu-
racy into discrimination (ability to separate classes) and
calibration (the ability to assign meaningful probabili-
ties to outcomes).
14 Stated in this way, the results of this
review indicate that doctors’ predictions of survival
have discriminatory ability even if they are poorly cali-
brated. The fact that physicians are able to distinguish
which patients are dying may be explained by the fact
that patterns such as lack of response to treatment, the
rate of disease progression, the onset of the
anorexia-cachexia syndrome, or the loss of will to live
may be recognised. That prognostic factors such as
performance status, symptoms, or use of cortico-
steroids, although independently significant, provided
little additional information is not surprising, as physi-
cians are likely to integrate this kind of information
and much else besides in their development of the
CPS.
The key issue with CPS is not so much whether or
how to improve physicians’ discriminatory ability;
rather it is how to supplement or support them in their
formulation of prognosis and, in particular, how to
enhance their calibration. Doctors need to be aware of
their tendency to overestimate prognosis in cancer
patients who are approaching death. This optimism
may have serious implications for the patient in terms
of inappropriate application of disease controlling
treatment and delays in referral to a hospice or pallia-
tive care. The results of the meta-analysis suggest that
survival of patients is typically 30% shorter than
predicted. Doctors need to consider adjusting their
predictions to take this into account, but arbitrarily
assigning a “correction factor” of 0.7 to their CPS
cannot be recommended.
Broad variation exists in the importance that
patients, bereaved family members, physicians, and
other care providers place on knowing the timing of
the terminally ill patients’ death,
2 but this ambivalence
should not contribute to a lack of calibration of
clinicians’ predictions. Accurate prognoses are impor-
tant not only for diagnostic and therapeutic decision
making but also for the selection and stratification of
the participants in clinical trials. McKillop has
proposed that prognostication has two aspects: the
“general prognosis” based on the tissue diagnosis and
its associated prognostic markers is incorporated with
the patient’s own physical and psychosocial attributes
to provide an “individual prognosis,” specific to the
person before the physician.
23 Such a model provides
the basis for understanding and improving the calibra-
tion of physicians’ predictions. The identification of
novel prognostic factors such as C reactive protein,
cytokines, and patient rated quality of life and the
development of clinical prediction tools may help to
recalibrate physicians’ predictions.
Unanswered questions and future research
Because CPS seems to be related to AS, further studies
that merely look at the accuracy of predictions or
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Further research is needed on whether the demo-
graphics, training, or experience of the doctor makes a
difference; whether the nature of the doctor-patient
relationship is important; whether predictions made at
follow up are superior to initial ones; and ways to
enhance the CPS. On the basis of our findings, CPS
could now be used as the reference standard for evalu-
ating other methods for predicting survival, and it has
been used for this purpose.
24 Understanding how doc-
tors formulate their predictions, and interventions that
train inexperienced doctors to make better predictions
are also worthy of consideration.
If doctors are better able to anticipate death, they
will be likely to be better able to make judicious use of
medical treatments and optimise the use of palliative
care, avoiding unnecessary treatments near the end of
life. They will also help patients to achieve a good
death if for no other reason than that they help to ful-
fil patients’ own expectations about the kind of
information they want. Although not all patients want
all the prognostic information all of the time, most
patients want most of the information most of the
time.
4 Doctors face two challenges in prognosticating
near the end of life: formulating accurate predictions
and communicating them. The former act, which has
been the subject of this review,is a predicate for the lat-
ter, but we believe that both are necessary for patients
to achieve a good death.
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What is already known on this topic
Accurate prediction of the timing of death is
important for good clinical decision making in the
care of patients with a terminal illness
Doctors’ survival predictions are not very accurate
and often overestimate survival
Though inaccurate, doctors’ predictions correlate
with survival
What this study adds
Doctors’ survival predictions become more
accurate closer to the date of death
Though inaccurate, predictions of up to six
months in length are nevertheless reliable, as they
are highly correlated with actual survival
Traditional prognostic indicators such as
performance status, anorexia, and breathlessness
add little information to that contained in the
physician’s prediction
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